Deconstructing Post Stroke Hemiparesis
Launched by PROVIDENCE VA MEDICAL CENTER · Aug 11, 2023
Trial Information
Current as of August 19, 2025
Recruiting
Keywords
ClinConnect Summary
The clinical trial titled "Deconstructing Post Stroke Hemiparesis" is focused on understanding the challenges that people face after having a stroke, especially with their arm and hand movements. By breaking down these difficulties into smaller parts, the researchers hope to connect these issues to specific areas of the brain. This study is currently looking for participants who have had a stroke more than six months ago and experience some trouble using their arm, but can still follow simple instructions in English.
To be eligible for this study, participants should be between the ages of 65 and 74 and have a specific level of motor impairment in their upper arm, as measured by a standard assessment. Those with previous significant arm difficulties before their stroke, certain medical conditions, or specific exclusions related to MRI and brain stimulation cannot participate. If you choose to join, you can expect to take part in assessments that help researchers understand your arm and hand function better, which may contribute to improved rehabilitation methods for stroke survivors in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Diagnosis of a unilateral ischemic stroke occurring \>6 months prior as documented in medical chart
- • Upper extremity motor impairment as measured by Fugl-Meyer Upper Extremity Assessment ≤60
- • Ability to follow simple instructions in English
- Exclusion Criteria:
- • Greater than moderate difficulty using the arm and hand pre-dating the stroke as assessed by the questions adapted from the QuickDASH outcome measure score on any question \>= 3, which measures physical function and symptoms in people with difficulty using the arm and hand.
- • Visual or auditory disorders resulting in the inability to see or hear, respectively, the stimuli presented as part of research sessions
- • Inability to maintain a seated position for at least one hour
- • Standard MRI exclusion (e.g., significant claustrophobia or inability to tolerate loud noises, cardiac pacemaker (unless MRI-safe), implanted device (deep brain stimulation) or metal in the brain, cervical spinal cord, or upper thoracic spinal cord)
- • Standard (single-pulse) TMS exclusion which include (in addition to those listed for MRI) pregnancy/lactation/planning to become pregnant during the study, seizure disorder, and primary or secondary CNS tumors
About Providence Va Medical Center
The Providence VA Medical Center is a leading healthcare institution dedicated to delivering high-quality medical care and advancing clinical research for veterans. As a sponsor of clinical trials, the center focuses on innovative therapies and treatment strategies that address the unique health challenges faced by the veteran population. With a commitment to ethical research practices and patient-centered care, the Providence VA Medical Center collaborates with multidisciplinary teams to ensure rigorous study design and implementation, ultimately aiming to improve health outcomes and enhance the quality of life for veterans.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Providence, Rhode Island, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported